186 related articles for article (PubMed ID: 35536326)
1. Inter-individual comparison of diagnostic accuracy of adrenal washout CT compared to chemical shift MRI plus the T2-weighted (T2W) adrenal MRI calculator in indeterminate adrenal masses: a retrospective non-inferiority study.
McPhedran R; Gerson R; Alfaleh H; Sathiadoss P; Schieda N
Abdom Radiol (NY); 2022 Jul; 47(7):2453-2461. PubMed ID: 35536326
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the T2-weighted (T2W) adrenal MRI calculator to differentiate adrenal pheochromocytoma from lipid-poor adrenal adenoma.
Gerson R; Tu W; Abreu-Gomez J; Udare A; McPhedran R; Ramsay T; Schieda N
Eur Radiol; 2022 Dec; 32(12):8247-8255. PubMed ID: 35680653
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
[TBL] [Abstract][Full Text] [Related]
4. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of 'Fat-Poor' Adrenal Adenomas at Chemical-Shift MRI.
Aldhufian M; Sheinis Pickovsky J; Alfaleh H; Melkus G; Schieda N
Can Assoc Radiol J; 2024 Feb; 75(1):98-106. PubMed ID: 37335612
[TBL] [Abstract][Full Text] [Related]
6. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
7. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MRI features in lipid-rich and lipid-poor adrenal adenomas using subjective and quantitative analysis.
Tu W; Gerson R; Abreu-Gomez J; Udare A; Mcphedran R; Schieda N
Abdom Radiol (NY); 2021 Oct; 46(10):4864-4872. PubMed ID: 34120206
[TBL] [Abstract][Full Text] [Related]
10. Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.
Loonis AT; Yu H; Glazer DI; Bay CP; Sodickson AD
AJR Am J Roentgenol; 2023 May; 220(5):693-704. PubMed ID: 36416399
[No Abstract] [Full Text] [Related]
11. Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.
Northcutt BG; Trakhtenbroit MA; Gomez EN; Fishman EK; Johnson PT
J Comput Assist Tomogr; 2016; 40(2):194-200. PubMed ID: 26978001
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria.
Kang S; Oh YL; Park SY
Abdom Radiol (NY); 2021 Mar; 46(3):1082-1090. PubMed ID: 32951125
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
14. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
15. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
Seo JM; Park BK; Park SY; Kim CK
AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
[TBL] [Abstract][Full Text] [Related]
16. A Critical Analysis of Computed Tomography Washout in Lipid-Poor Adrenal Incidentalomas.
Akbulut S; Erten O; Kahramangil B; Gokceimam M; Kim YS; Li P; Remer EM; Berber E
Ann Surg Oncol; 2021 May; 28(5):2756-2762. PubMed ID: 33210268
[TBL] [Abstract][Full Text] [Related]
17. The adrenal mass: correlation of histopathology with imaging.
Yip L; Tublin ME; Falcone JA; Nordman CR; Stang MT; Ogilvie JB; Carty SE; Yim JH
Ann Surg Oncol; 2010 Mar; 17(3):846-52. PubMed ID: 19960266
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnostic value of plain CT scan in adrenal adenoma and non-adenoma: A two-center control study of mean attenuation value, minimum attenuation value, and CT histogram.
Han Z; Wu M; Wei P; Zhu H; Zhang X; Ding Z; Zhang M
Front Endocrinol (Lausanne); 2022; 13():1007870. PubMed ID: 36440234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
